Wondering if you could qualify to join a clinical trial for people living with scleroderma? Let’s talk about what determines your eligibility. Clinical trials can offer access to promising new...
Read More
Join SPIN for their online event on November 22! The SRF is partnering with the Scleroderma Patient-centered Intervention Network (SPIN) and international partners for "What’s New in Scleroderma Research: An...
Read More
The Scleroderma Research Foundation was proud to participate as a Strategic Collaborator in the inaugural meeting of Vie Ventures’ Therapeutics Advisory Council (TAC), held September 9 in New York City....
Read More
Get excited for this year’s Cool Comedy • Hot Cuisine with our new highlight video. As summer winds down, we’re ramping up for one of the most anticipated events of...
Read More
Watch now: How Dr. Michael Longaker, Stanford University and SRF-Funded researcher, brings a unique perspective to solving scleroderma. Right now, you have a powerful opportunity to accelerate critical scleroderma research....
Read More
Big news for scleroderma research: NIH Strategic Plan highlights autoimmune diseases 🔬 We are encouraged by the recent publication of the NIH‑Wide Strategic Plan for Autoimmune Disease Research for 2026–2030....
Read More
Right now, you have the power to fund critical scleroderma research by donating to the SRF Research Challenge. 🔬 When you give, you can help uncover new therapies, fund cutting-edge...
Read More
🎥 Watch Kimberly (dx 2008) share why she believes that funding research is key to finding a cure. Join her in supporting the SRF Research Challenge by donating today. At...
Read More
Early results presented from the RESET-SSc trial showed that two people with systemic sclerosis (scleroderma) experienced reduced skin thickening after receiving rese-cel, an investigational CAR T-cell therapy. Both were also...
Read More
Vie Ventures Co-founders SRF Chairman Luke Evnin, PhD, left, and Dr. Steven St. Peter. Photo: TOM DODGE/NEW VIEW MEDIA San Francisco, CA (July 9, 2025)— The Scleroderma Research Foundation (SRF) is proud...
Read More
